Loeb & Loeb LLP is proud to sponsor the American Conference Institute’s (ACI) Summit on Biosimilars & Innovator Biologics taking place from June 28-29, 2022 where partner Ryan Hagglund will be speaking on the panel "Satisfying the Statutory Requirements for Enablement and Written Description: §112(a) and the Future of Genus Claims" on June 28.
From event website:
Join the “who’s who” of the biosimilars and innovator biologics industries in Boston this June. Join distinguished speakers, including leading in-house counsel and representatives from key government agencies and trade associations. Engage in lively discussion and debate with thought leaders on up-to-the-minute trends and hot-button issues.
For more information, including how to register, please visit the event website.